John Patience

Insider Reports History

Reporting-owner location: Lake Forest, IL
Latest reporting-owner signature: /s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Patience

Form 4 holding Director, Chairman

BIODESIX INC

Security class: Common Stock
Shares / value: 241,480
Estimated value: $1,642,064
Report date: 31 Mar 2026
Price: $6.80
Ownership: By John Patience Living Trust dated 7/23/1993

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class: Common Stock
Shares / value: 653,224
Estimated value: $1,025,562
Report date: 03 Dec 2024
Price: $1.57
Ownership: By John Patience Living Trust dated 7/23/1993

Form 4 holding Director, Chairman

BIODESIX INC

Security class: Common Stock
Shares / value: 107,664
Estimated value: $732,115
Report date: 31 Mar 2026
Price: $6.80
Ownership: By Patience Enterprises LP

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class: Common Stock
Shares / value: 214,046
Estimated value: $336,052
Report date: 03 Dec 2024
Price: $1.57
Ownership: By Patience Enterprises LP

Form 4 holding Director, Chairman

BIODESIX INC

Security class: Common Stock
Shares / value: 24,022
Estimated value: $163,349
Report date: 31 Mar 2026
Price: $6.80
Ownership: Direct

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class: Restricted Stock Units
Shares / value: 66,667
Estimated value: $52,000
Report date: 20 May 2024
Price: $0.7800
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, Chairman

BIODESIX INC

Security class: Common Stock
Shares / value: 2,649
Estimated value: $18,013
Report date: 31 Mar 2026
Price: $6.80
Ownership: By Spouse

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class: Common Stock
Shares / value: 3,941
Estimated value: $6,187
Report date: 03 Dec 2024
Price: $1.57
Ownership: By IRA

Form 4 holding Director, Chairman

BIODESIX INC

Security class: Restricted Stock Units
Shares / value: 4,082
Estimated value: $0
Report date: 31 Mar 2026
Price: $0.9242
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class: Common Stock Warrants (right to buy)
Shares / value: 16,666
Estimated value
Report date: 23 Jan 2024
Price
Ownership: By John Patience Living Trust dated 7/23/1993
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, Chairman

BIODESIX INC

Security class: Stock Options (Right to Buy)
Shares / value: 6,354
Estimated value
Report date: 02 Jan 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by John Patience

4 BDSX

BIODESIX INC

Report period: 31 Mar 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Apr 2026, 16:52
Role: Director, Chairman
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 02 Jan 2026
Transactions: 4
Transaction value: $0
Accepted by SEC: 06 Jan 2026, 16:26
Role: Director, Chairman
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 30 Sep 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Oct 2025, 16:04
Role: Director, Chairman
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 30 Jun 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Jul 2025, 16:33
Role: Director, Chairman
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 20 May 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 22 May 2025, 16:16
Role: Director, Chairman
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 31 Mar 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Apr 2025, 16:25
Role: Director, Chairman
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 03 Dec 2024
Transactions: 1
Transaction value: +$314,000
Accepted by SEC: 03 Dec 2024, 20:48
Role: Director
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 05 Nov 2024
Transactions: 1
Transaction value: +$103,710
Accepted by SEC: 06 Nov 2024, 15:16
Role: Director, Chairman
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 21 May 2024
Transactions: 4
Transaction value: $0
Accepted by SEC: 23 May 2024, 19:12
Role: Director, Chairman
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 20 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 May 2024, 19:02
Role: Director
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 05 Apr 2024
Transactions: 1
Transaction value: +$250,010
Accepted by SEC: 09 Apr 2024, 19:33
Role: Director, Chairman
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 23 Jan 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 25 Jan 2024, 16:10
Role: Director
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 01 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Jan 2024, 16:14
Role: Director, Chairman
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 03 Aug 2023
Transactions: 1
Transaction value: +$99,999
Accepted by SEC: 07 Aug 2023, 17:32
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 28 Jun 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Jun 2023, 17:59
Role: Director
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 29 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jun 2023, 18:27
Role: Director
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 23 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 25 May 2023, 18:22
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 03 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jan 2023, 15:31
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 01 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jan 2023, 17:21
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 21 Nov 2022
Transactions: 1
Transaction value: +$2,000,000
Accepted by SEC: 21 Nov 2022, 17:03
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 31 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Jun 2022, 16:21
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 24 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 26 May 2022, 16:15
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 07 Apr 2022
Transactions: 1
Transaction value: +$499,999
Accepted by SEC: 11 Apr 2022, 16:39
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 30 Dec 2021
Transactions: 2
Transaction value: +$699,998
Accepted by SEC: 04 Jan 2022, 15:59
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 23 Nov 2021
Transactions: 1
Transaction value: +$61,753
Accepted by SEC: 24 Nov 2021, 13:57
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 18 Nov 2021
Transactions: 1
Transaction value: +$60,220
Accepted by SEC: 22 Nov 2021, 14:33
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 30 Sep 2021
Transactions: 1
Transaction value: +$166,671
Accepted by SEC: 10 Dec 2021, 14:57
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 19 Aug 2021
Transactions: 1
Transaction value: +$67,490
Accepted by SEC: 23 Aug 2021, 15:01
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 17 Aug 2021
Transactions: 1
Transaction value: +$11,416
Accepted by SEC: 19 Aug 2021, 15:00
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 29 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jul 2021, 18:21
Role: Director, Chairman, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 20 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 May 2021, 21:59
Role: Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for John Patience

Insider Reports Filed by John Patience